{"schema_version":"secwatch.filing_event.v1","accession":"0001161697-22-000132","form_type":"8-K","ticker":"KRMD","cik":"0000704440","company_name":"KORU Medical Systems, Inc.","filed_at":"2022-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.476493+00:00","generated_at":"2026-06-27T02:38:38.349662+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"KORU Medical Q4 revenue up 60% to $6.5M, but full-year net loss widens to $4.6M","bullets":["Q4 net revenues $6.5M (+60% YoY); adjusted growth 27.6% excluding prior-year inventory stocking.","Full-year net loss $4.6M ($0.10 per share) vs $1.2M loss in 2020; adjusted EBITDA ($1.8M) vs $3.7M.","Ended 2021 with $25.3M cash; expects FY2022 revenue of $26-27M with gross margin exit run rate 60%.","Expanded label indications with three 510(k) clearances; announced strategic plan targeting $60M revenue by 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001161697-22-000132","json":"https://secwatch.observer/filing/0001161697-22-000132.json","markdown":"https://secwatch.observer/filing/0001161697-22-000132.md","text":"https://secwatch.observer/filing/0001161697-22-000132.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/704440/000116169722000132/0001161697-22-000132-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/704440/000116169722000132/form_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T02:38:38.349662+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}